THE WORLD’S LEADING AI IN MEDICINE SUMMIT

Bringing together a unique ecosystem of clinicians, technologists and C-Suite executives
Creating a future where AI will revolutionise health
Gain 20 CPD points by attending world-class medical presentations

11TH – 12TH SEPTEMBER 2019

BASEL SWITZERLAND

BOOK NOW

2000
ATTENDEES

100
SPEAKERS

68
COUNTRIES

5
TRACKS

WHAT’S INTELLIGENT HEALTH? 

The only large-scale, global summit focused purely on AI in healthcare – And CPD Accredited! Intelligent Health gathers the world’s brightest AI health brains from pharmaceutical, biotech, medtech, health provisions, clinicians, tech companies, startups, investment and science every September in Switzerland. We work in line with the UN Sustainable Development Goals and have a big focus on making sure the benefits of AI are distributed globally.

The mission? To progress discussions about how AI can be used to prevent and solve some of the world’s greatest healthcare problems, improve the health of the human race and set the global AI agenda in healthcare for 2020 and beyond.

What’s on? Two jam-packed days of health tech goodness. Think like a physician and code like a developer, with practical, real-world AI use cases, deep dive tech talks, announcements from the tech giants, nitty-gritty coding and AI clinicians workshops, hear from the health tech transformers of tomorrow and of course, passionate debate on social and behavioural determinants of health, ethics and AI for global health.

What’s new in 2019? The IH stage is growing to 5 tracks, including a dedicated deep dive technical stream looking at fundamental breakthroughs using AI which will change lives and reshape healthcare. The addition of a startups stage of AI health transformers, to hear from the CEOs and Founders of the most disruptive AI health tech companies of tomorrow. More dedicated content for CMIOs and clinicians with hands-on workshops and sessions to solve real-world problems. And for the first time, we have a Q&A stage so you can pick the brains of the greatest minds in applying AI in healthcare. Exciting!

“Energizing, uplifting and educational! The best of AI without the hype – truly about how AI can impact and improve the health of all people, across diverse geographies, diseases and resources. It was exciting to see how many clinicians participated”

Vice President, Strategic Data and Digital, US Oncology, Novartis

Inspiring, Energizing. Thoughtful. Provocative

Strategic advisor to CEOs of digital health, STEM and education initiatives

Lesley-Anne Long & Associates

Unlike any I've attended before - It was a unique combination of science and glamour - all presented in a format that kept my full attention

Co-Founder and Chief Science Officer

Lapetus

A great pioneering event that gets health care providers, hospitals, data scientists, startups and corporates together to talk about challenges and disruptive changes and how to get them realised. Great energy and great insights.

Consultant Cardiac Anaesthetist, AMC & Founder

Healthplus.ai

WHO’S COMING

Pharma, Biotech and Medical Device, Hospitals, Health, Practices, Clinicians, Big Tech, Health tech AI, Startups, Health insurers, Academics, Investors, Associations

CEO, CTO, COO, CIO, CMIO, CMO, Chief Data Officer, Chief Digital Officer, Chief Scientific Officer

VP, Director, Head of, Managing Director, Head of  Technology/AI/ Machine Learning/ Computer Vision/ Cognitive Computing/Technology/ Innovation/Data Science/ Data Analytics/ Data Strategy

Clinicians/ healthcare professionals in pharma & biotech 

Heads of, Directors, Consultants in Oncology, Radiology, Pathology, Medicinal Chemistry, Cell Therapy, Rare diseases, Biosimilars, Imaging, Diabetes, Opthamology, Cardiology, Diagnostics

KEY THEMES 2019

THE FUTURE OF HEALTHCARE Where can AI take us with practical, real-world AI use cases

DEEP DIVE AI TECH TALKS Fundamental breakthroughs using AI which will change lives and reshape healthcare

REGULATORS PERSPECTIVES The evolving narrative on how you regulate a device that uses a self-improving algorithm?

MINISTERS PERSPECTIVE Addressing social and behavioural determinants for health using AI

CLINICIANS AND CMIOs PERSPECTIVE How can technologists convince clinicians and CMIOs that AI works and get them to use it?

CONSUMER EMPOWERMENT How to provide better insight into medical data to help healthcare consumers make more informed health decisions

CHINA How China’s tech giants are delivering smart health services, driven by the internet and AI

AI HEALTH TRANSFORMERS Hear from the CEOs and Founders of the most disruptive health tech companies of tomorrow

AI IN GLOBAL HEALTH The latest in population level application of AI in healthcare and tracking progress made towards the health-related Sustainable Development Goals

THE CLINECT CHALLENGE

“Calling all clinicians, clinical commissioning groups, public bodies, charities and any other professionals facing a digital health challenge” 

Clinect Challenge is an open, collaborative set of projects addressing real-life digital health challenges.

Groups of vendors and project Champions will work together over a 6 month period on a rapid fire proof of concept project with the goal of presenting the theoretical outcome at Intelligent Health 2019 – The World’s Leading AI in Medicine Summit.

Each Challenge group will be given a demonstration pod within the Clinect Challenge zone and the opportunity to meet with senior healthcare, education and technology delegates from around the Globe.

ABOUT CLINECT

MEET THE AI HEALTH BRAINS 2019

DR. HEATHER BERLIN

Neuroscientist & Assistant Professor of Psychiatry

Icahn School of Medicine at Mount Sinai

DR. HEATHER BERLIN

Neuroscientist & Assistant Professor of Psychiatry

Icahn School of Medicine at Mount Sinai

Dr. Heather Berlin is a cognitive neuroscientist and Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. She practices clinical neuropsychology at Weill Cornell Medicine/New York Presbyterian Hospital in the Department of Neurological Surgery, and is a Visiting Scholar at the New York Psychoanalytic Society and Institute. She explores the neural basis of impulsive and compulsive psychiatric and neurological disorders with the aim of developing novel treatments. She is also interested in the brain basis of consciousness, dynamic unconscious processes, and creativity.

 

Passionate about science communication and promoting women in STEM, Berlin is a committee member of the National Academy of Sciences’ Science and Entertainment Exchange, and The New York Times series TimesTalks. She hosts Startalk All-Stars with Neil DeGrasse Tyson, and hosted the PBS series Science Goes to the Movies, and the Discovery Channel series Superhuman Showdown. Dr. Berlin co-wrote and starred in the critically acclaimed off-Broadway and Edinburgh Fringe Festival show, Off the Top, about the neuroscience of improvisation. She has made numerous media appearances including on the BBC, History Channel, Netflix, National Geographic, NPR, and TEDx, and was featured in the documentary film Bill Nye: Science Guy. She received her Ph.D. from the University of Oxford and Master of Public Health from Harvard University.

JENNIFER ESPOSITO

Vice President – Health

Magic Leap

JENNIFER ESPOSITO

Vice President – Health

Magic Leap

With 20 years of experience, Jennifer brings deep healthcare, life sciences and biotechnology industry expertise along with a foundation in information and communication technology, and a view that spans across multiple other industries. Jennifer has a graduate degree from the Dartmouth Institute for Health Policy and Clinical Practice at Dartmouth College where she focused on Epidemiology and Biostatistics. She is a full member of the American Association of Physicists in Medicine.

Jennifer travels extensively around the world, regularly meeting with top leaders in industry and government. Jennifer advises start-ups focused on digital health, biotechnology, VR and artificial intelligence. She is active in policy initiatives on global health security and digital health, identifying novel ways technology can be used to advance the Sustainable Development Goals (SDGs).

 

DR. ALAIN DAGHER

Neurologist and Professor

Montreal University

DR. ALAIN DAGHER

Neurologist and Professor

Montreal University

Dr. Dagher is an M.D./Ph.D. who studied Electrical Engineering and Medicine. He is a Neurologist and Professor at McGill University in Montreal (clinician and scientist). His research aims to understand brain reward systems and their role in neurological and psychiatric illness. He uses brain imaging, notably functional magnetic resonance imaging (fMRI), to map brain activity in response to drugs or natural rewards like food and music. He is particularly interested in figuring out what in the brain makes individuals vulnerable to mental illness. He splits his professional life between clinical neurology and research and teaching. He sees people with Parkinson’s Disease in his clinic once a week. Dr. Dagher teaches medical students and Ph.D. students in neuroscience.

DR. ANN AERTS

Member of the Board of Trustees and Head

Novartis Foundation

DR. ANN AERTS

Member of the Board of Trustees and Head

Novartis Foundation

Dr. Ann Aerts has been Head of the Novartis Foundation since January 2013, where she has played a key role in devising new policy recommendations. She has the exciting responsibility of heading an organization committed to exploring innovative solutions to public health problems. The Novartis Foundation has the challenging goals of expanding access to quality healthcare and eliminating diseases such as leprosy and malaria. Before her current role, Ann was Franchise Medical Director Critical Care for Novartis Pharma in Basel and Therapeutic Area Head Cardiovascular and Metabolism in Novartis Pharma Belgium.

Prior to joining Novartis, she served as Director of the Lung and Tuberculosis Association in Belgium, as Head of the Health Services Department of the International Committee of the Red Cross (ICRC) in Geneva and was Health Coordinator for the ICRC in several countries.

PROF. ALEXANDER NAVARINI

Head of the Department of Clinical Medicine

University of Basel

PROF. ALEXANDER NAVARINI

Head of the Department of Clinical Medicine

University of Basel

Alexander Navarini is a clinical-scientist physician based in Basel, Switzerland. He is a quantitative dermatologist, experimental immunologist and trained in modern genetics.

Born in Basel, raised in Kantons GR and AG, medical studies in Basel and Paris. Training as MD PhD experimental immunologist in Zurich. Residency in internal medicine at Bruderholzspital, tropical medicine at Swiss Tropical Institute, and dermatology at University Hospital Zurich. Senior resident research fellowship in modern genomics at King’s College London. Was attending physician and deputy head of outpatient clinic at Department of Dermatology, University Hospital Zurich. Since November 2018 Chair of Dermatology at the University Hospital of Basel.

PROF. PETER SCHMID-GRENDELMEIER

Head Allergy Unit, Dept. Of Dermatology

University Hospital Zürich

PROF. PETER SCHMID-GRENDELMEIER

Head Allergy Unit, Dept. Of Dermatology

University Hospital Zürich

Professor Peter Schmid-Grendelmeier was Swiss board certified for Dermatology in 1995 and Allergology in 1997 and became Professor for Allergy and Dermatology in 2003 at the University of Zürich, Switzerland. Since 2003, he has also been the head of the Allergy Unit of the Department of Dermatology of the University Hospital of Zürich.

His research focus is namely atopic dermatitis, urticaria and inhalant allergies; focusing on molecular allergy diagnosis and therapy. In addition he has a strong interest in tropical allergic skin diseases, having worked for several years in Peru and Tanzania. Professor Schmid-Grendelmeier has published more than 150 original articles and is a member of the editorial or review board of several well-established journals.

He serves on the board of various national and international societies. Currently he is President of the Swiss Society for Allergy and Clinical Immunology (SSAI) and EAACI Vice President for Education and Specialty. He is also Director of Education at the Christine Kühne Center for Allergy Research and Education (www.ck-care.ch). Professor Peter Schmid-Grendelmeier also co-chairs the Swiss Expert group for Urticaria and is a member of the EAACI/WAO/AAAAI Urticaria Guideline Board.

DR. PATRICE MATCHABA

Member of the Board of Trustees, Novartis Foundation and Group Head of Global Health and Corporate Responsibility

Novartis

DR. PATRICE MATCHABA

Member of the Board of Trustees, Novartis Foundation and Group Head of Global Health and Corporate Responsibility

Novartis

Patrice Matchaba, M.D., has been Global Head of Corporate Responsibility for Novartis since October 1, 2017.

Dr. Matchaba most recently served as Global Head of the Cardio-Metabolic development unit at Novartis, where he led the global clinical development of the cardio-metabolic portfolio. He joined Novartis South Africa in 2000 as the Country Pharma Organization Chief Scientific Officer. Since moving to Novartis Pharmaceuticals Corporation in the United States in 2002, he has held several roles of increasing responsibility such as Therapeutic Area Head for Immunology and Infectious Diseases; Global Head of Drug Safety and Epidemiology; and Global Head of the Integrated Development Functions and Regions, which include Global Clinical Operations, Global Clinical Submissions, Integrated Information Sciences, Development Informatics, Development Diversity and Inclusion, and all Medical Country Pharma Organization regions.

Dr. Matchaba completed his medical training at the University of Zimbabwe, and is a fellow of the College of Obstetrics and Gynecology South Africa. In addition, he is a graduate of Harvard Business School’s Program for Management Development.

DR. BART GEERTS

Consultant Cardiac Anaesthetist & CEO

AMC & Healthplus.ai

DR. BART GEERTS

Consultant Cardiac Anaesthetist & CEO

AMC & Healthplus.ai

Dr. Bart Geerts is the founder and CEO of Amsterdam startup Healthplus.ai with tools to predict depression relapse through mobile app use, readmissions for chronic heart failure for cardiologists via home monitoring, 3D bone segmentation for orthopaedic and trauma surgeons and in-hospital infections.

 

He is an active physician and has over ten years of clinical experience as an anaesthetist, intensivist and clinical pharmacologist in the Netherlands and UK. He has managed a research group of more than ten scientists with a focus on medical technology and big data.

 

Bart has years in Pharma and AI. He has worked on several innovation projects in hospital consortia regarding digital health. He has studied medicine (MD), biomedical sciences (MSc), intensive care medicine (PhD), and global business (MBA at IE University).

ALEXANDER FINLAYSON

GP and Co-Founder

Nye, and Doll Fellow, Oxford University

ALEXANDER FINLAYSON

GP and Co-Founder

Nye, and Doll Fellow, Oxford University

Alexander is a co-founder of Nye, an early stage healthcare company with a big dream to build a health system which maximises welfare and an individual’s ability to flourish. He is also a practicing primary care physician and on the faculty at Oxford University. He was previously a Kennedy Scholar at Harvard University where he studied System Biology and Genetics and was the Head of Research at the King’s Centre for Global Health. In 2008, Alexander started an award-winning health technology company which delivers health system capacity building in fragile states, with a particular focus on Somalia. Most recently MedicineAfrica and partners were awarded the first of UKAID’s flagship global Higher Education programme, Strategic Partnerships in Higher Education Innovation and Reform (SPHEIR). He likes to ski and play the bagpipes.

NAOMI LEE

Executive Editor – Digital

The Lancet

NAOMI LEE

Executive Editor – Digital

The Lancet

Naomi handles peer review and commissioning for The Lancet with a special interest in surgery, health informatics, and medical technology. As part of the marketing and communications team, she is also leading the digital transformation of The Lancet group. Naomi trained in surgery, specializing in urology and has worked in the United Kingdom, Argentina, and Mexico. She studied medicine at Cambridge University and King’s College London, and is currently studying data science at University College London. Naomi joined The Lancet in 2014.

SARAH PORTER

CEO and Founder

InspiredMinds

SARAH PORTER

CEO and Founder

InspiredMinds

Sarah Porter has launched 21 b2b and b2c technology products in 11 countries since 1996 and has a renowned reputation for taking ideas from concept to market with subsequent significant growth globally.

Emerging tech / AI / Medtech / Singularity / existentialism is where her core experience lies and she has over 20 years of commercial experience.

As a board executive for i2i events (parent company The Guardian Media Group / Apax – Ascential – previously Top Right Group) with the specific remit to rapidly grow the business whilst leveraging operational costs and prepare pre IPO. She sat on the i2i mergers and acquisitions committee identifying, analysing and approaching target businesses and accelerated growth by 22% within 12 months.

Achievements include the launch and acquisition of Money 2020 – a leading fintech product. This included negotiation, 3 stage due diligence, its subsequent integration, and the long term geo-adaption into a global portfolio worth over $40m. The launch of World Retail Congress in 10 countries, the re-launch of Cannes Lions festival.

Sarah is a regular keynote speaker on start-ups, business and women / equality related issues and is an ambassador for the Royal Marsden where she champions the use of AI tech in oncology advances.

BABITA SHARMA

Television Presenter

BBC

BABITA SHARMA

Television Presenter

BBC

Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel, BBC World News, and presenting the show Newsday.

Babita has presented the finance programme Your Money, and fronts business reports for BBC News. She has also covered economic and political stories from around the world.

GET READY TO BE INSPIRED

How many global health problems can we solve using AI?

How can we disrupt old systems from a reactive model to a predictive and preventative model?

From coding to cancer- how can AI make its mark in healthcare?

How should we govern emerging technologies in healthcare?

How can AI be used to do the legwork and speed up drug discovery?

What are the tech giants and AI startups working on to get deep learning into hospitals, clinics and smartphones?

Where are the opportunities to improve clinical practice and augment the healthcare professional?

How can we use AI to shape the way we handle our future well-being?

Intelligent Health
Intelligent Health Intelligent Health Intelligent Health Intelligent Health
Intelligent Health
Intelligent Health Intelligent Health

FEATURED SPONSORS

Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health

SUPPORTERS

ADVISORS

Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health

2018 SPEAKERS

Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health
Intelligent Health